1,501 Shares in Repligen Co. (NASDAQ:RGEN) Bought by Trevian Wealth Management LLC

Trevian Wealth Management LLC purchased a new position in Repligen Co. (NASDAQ:RGEN – Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 1,501 shares of the biotechnology company’s stock, valued at approximately $223,000. Repligen makes up approximately 0.2% of Trevian Wealth […]

Leave a Reply

Your email address will not be published.

Previous post Citigroup Upgrades Basf (OTCMKTS:BASFY) to “Hold”
Next post BMW Set to Build Skytop in Limited-Run Small-Series Model